Home > Insider Trading > Filing (0001567619-19-023733)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221590	Jacques Jean Bienaime	C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-26	3,000	$21.51	330,530	No	4	M	Direct
Common Stock	Disposition	2019-12-26	3,000	$86.43	327,530	No	4	S	Direct
Common Stock	Acquisiton	2019-12-27	5,000	$21.51	332,530	No	4	M	Direct
Common Stock	Disposition	2019-12-27	5,000	$86.16	327,530	No	4	S	Direct
Common Stock	Disposition	2019-12-03	630	$0.00	180,261	No	5	G	Indirect	Shares held by Jean-Jacques Bienaime Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	5	G	Indirect	Shares held by Jean-Jacques Bienaime Family Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy Common Stock)	Disposition	2019-12-26	3,000	$0.00	3,000	$21.51
Common Stock	Stock Option (Right to buy Common Stock)	Disposition	2019-12-27	5,000	$0.00	5,000	$21.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
120,000	2010-11-12	2020-05-11	No	4	M	Direct
115,000	2010-11-12	2020-05-11	No	4	M	Direct

Footnotes

Trade made pursuant to a 10b5-1 plan executed on June 11, 2019.
On November 26, 2019, the reporting person filed a Form 4 which inadvertently reported a gift of 450 shares made from the reporting person and not from the reporting person's trust. This Form 4 corrects such error by increasing the total amount of securities beneficially owned by the reporting person by such 450 shares.
The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.
Trade made pursuant to a 10b5-1 plan executed on September 6, 2019.
On December 3, 2019 the reporting person gifted 630 shares to a charitable organization.
On November 26, 2019, the reporting person filed a Form 4 which inadvertently reported a gift of 450 shares made from the reporting person and not from the reporting person's trust. This Form 4 corrects such error by decreasing the total amount of securities beneficially owned by the reporting person's trust by such 450 shares.
Reflects the number of options outstanding after the transactions from this specific stock option grant.